Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0822-2017Class II

Femoral Shaft L=120mm; Femoral Shaft L=135mm; Femoral Shaft L=150mm The product is a component is a systems...

Stanmore Implants Worldwide, Ltd. / initiated 2016-12-07 / Terminated / root cause: packaging

Stanmore Implants Worldwide Ltd. began a recall of Femoral Shaft L=120mm; Femoral Shaft L=135mm; Femoral Shaft L=150mm The product is a component is a systems that is intended for the replacement if diseased or... on . FDA classified it as Class II and gives the reason as "The recalling firm has received 5 customer inquiries reporting that at least one pouch of the double pouch packaging configuration has been punctured by the tip of the device's stem". As of , the recall status on record is Terminated, and MDM tags the root cause as packaging.

Recall record

Recall number
Z-0822-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Stanmore Implants Worldwide, Ltd.
Product
Femoral Shaft L=120mm; Femoral Shaft L=135mm; Femoral Shaft L=150mm The product is a component is a systems that is intended for the replacement if diseased or deficient bone around the knee joint, distal femur, proximal femur or total femur bone
Product code
KRO Prosthesis, Knee, Femorotibial, Constrained, Cemented, Metal/Polymer
Reason for recall
The recalling firm has received 5 customer inquiries reporting that at least one pouch of the double pouch packaging configuration has been punctured by the tip of the device's stem.
Root cause tag
packaging
FDA root cause
Packaging
Action
Stanmore Implants sent an Urgent Field Safety Notice dated November 25, 2016, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were advised to immediately check their internal inventory and quarantine all subject devices, circulate the Field Safety Notice internally to all interested/affected parties, maintain awareness of the notice internally until all required actions have been completed within their facility, inform Stanmore Implants if any of the subject devices have been distributed to other organizations, complete the attached customer response form and list of affected batches form, return the completed form and any affected devices to their S/W Representative. Customers with questions were instructed to contact their local sales representative.
Quantity in commerce
11 units
Distribution
Nationwide Distribution to OH, NE, FL, LA, NY, TX, MS, MD, CT, AL, PA
Product codes and lots
B10191, B10443, B9920, B10561, B9921, B9922

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0822-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0820-2017Class IITerminatedVoluntary: Firm initiated
Z-0821-2017Class IITerminatedVoluntary: Firm initiated
Z-0822-2017Class IITerminatedVoluntary: Firm initiated
Z-0823-2017Class IITerminatedVoluntary: Firm initiated
Z-0824-2017Class IITerminatedVoluntary: Firm initiated